UltraTech Cement: targets up to ₹15,210 on expansion

Brokerages stay constructive on frontline names

Brokerage houses remain constructive on select frontline stocks, pointing to improving fundamentals and valuation comfort. In cement, Goldman Sachs reiterated a positive stance on UltraTech Cement, citing operating performance and execution on expansion and cost efficiency. Separately, Elara Capital flagged a positive view on BPCL, pointing to robust refining margins, easing LPG losses and a strengthened balance sheet.

UltraTech Cement stood out in early trade as investors reacted to a cluster of brokerage notes and target-price revisions. The focus across reports stayed consistent: capacity expansion, improving demand conditions, and a multi-year cost-efficiency program. Analysts also pointed to UltraTech’s ability to fund expansion largely through internal accruals, which can reduce balance sheet strain during an aggressive capex cycle.

UltraTech Cement stock reaction on the day

At 10:27 am, UltraTech Cement shares were trading at ₹12,723.80, up 2.87% from the previous close on the BSE. The move followed what the reports described as a strong quarterly performance and improving visibility on volumes.

Market commentary in the notes suggested investors are tracking two things closely. First is the pace of capacity additions in FY26 and FY27. Second is the extent to which the company can protect per-tonne profitability as demand and pricing evolve.

Elara Capital: Accumulate with a higher target

Elara Capital reiterated its Accumulate rating on UltraTech Cement and raised its target price to ₹14,553 from ₹14,088. The brokerage said the company is positioned to outpace industry growth as demand improves and recently added capacities ramp up through organic and inorganic routes.

Elara argued that UltraTech’s expansion pipeline improves medium-to-long-term volume visibility. It also expects margins to benefit from cost-efficiency initiatives, including focused efficiency capex at ICEM and KCL. In its note, Elara said it raised its EBITDA estimate by 7% for FY26E while largely retaining estimates for FY27E-28E.

The valuation anchor in Elara’s note was also explicit. As it rolled over to December 2027E from September 2027E, it raised the target price to ₹14,553 from ₹14,088 on 18x (unchanged) December 2027E EV/EBITDA. Elara flagged key risks as sub-par demand, weak cement prices, and a sharp rise in fuel prices.

Choice Institutional Equities: Buy on expansion visibility

Choice Institutional Equities maintained a Buy rating on UltraTech Cement with a target price of ₹15,210, stating that its core investment thesis remains unchanged. Analysts Prashanth Kumar Kota and Ashutosh Murarka cited continuous capacity expansion plans and clearer visibility on volume growth.

Choice highlighted planned additions of around 8 million tonnes (MT) of capacity in Q4FY26 and 12 MT in FY27E. It also pointed to funding expansion largely through internal accruals, a proactive cost-optimisation strategy, and a favourable sectoral pricing environment. Another factor cited was significant demand growth expected from the southern market.

Choice also disclosed valuation implications at its target price. On ₹15,210, FY28E implied EV/EBITDA, P/BV and P/E multiples stand at 19.0x, 4.5x and 31.7x, respectively.

Goldman Sachs: ‘Top pick’ view and price-hike signal

A Reuters market update noted UltraTech Cement rose 2.4% to ₹11,496 and was among the top gainers on the Nifty 50 on that day. Goldman Sachs reiterated a Buy, called UltraTech its “top pick” in the sector, and set a target price of ₹12,650 in that report. Goldman’s rationale referenced “healthy price hikes in April and May” supporting higher profitability per tonne in the cement industry, despite weaker-than-expected volumes.

Separately within the provided brokerage roundup, Goldman Sachs was also cited as maintaining a Buy while increasing its target price to ₹12,580 from ₹12,460. That note linked the view to volume growth recovery and lower costs contributing to a margin beat, alongside UltraTech’s balance sheet strength, ongoing cost savings, timely capacity expansions, and pricing power.

Other brokerage targets cited in the roundup

The compilation also referenced other brokerage calls on UltraTech Cement. These include Sharekhan’s Buy view with a price target of ₹14,200 and Nomura’s Buy view with a target price of ₹12,800 (cited alongside a sector stance that long-term tailwinds could support higher volume growth and sustainable cost-saving measures). JP Morgan was cited as maintaining an Overweight rating with a target price of ₹13,470.

The breadth of targets matters because it shows the market is debating valuation versus execution rather than direction of travel. While some notes flagged that valuations are not cheap, their stance remained supported by scale, consolidation trends, and the pace of capacity additions.

Snapshot: key numbers and broker calls

Company and trading context shared in the data

The data also included a brief company snapshot and trading metrics. UltraTech Cement was described as India’s largest and the world’s third-largest cement maker (ex-China) with capacity of 150.7 MTPA, operating across India, UAE, Bahrain, and Sri Lanka. It was also described as having a network of 34,500 dealers, 1,03,200 retailers, and 321 RMC plants.

A ticker table in the input listed UltraTech Cement’s market cap at ₹3,01,926 crore, free float at 39.45% of market cap, and 52-week high/low at 12,145.35 / 9,250.00. It also listed a P/E of 48.31 versus an industry P/E of 40.52.

Market impact: what investors are watching

The immediate market impact was visible in the stock’s intraday rise alongside a set of reiterated ratings and raised targets. The brokerage notes emphasised that UltraTech’s capex and integration of acquired assets can be central to sustaining volume growth.

At the same time, risks flagged by analysts keep the debate grounded. Elara explicitly highlighted sub-par demand, weak cement prices, and a sharp rise in fuel prices as key risks. The combination of expansion-led growth and cost control is therefore being weighed against the cyclicality of pricing and energy inputs.

Why the brokerage cluster matters

Multiple brokerages aligning on expansion visibility tends to reduce uncertainty around near-term execution, especially when capacity additions are quantified, as in Choice’s note. Targets also provide a range of valuation views, from low-₹12,000s to above ₹15,000, suggesting the market is pricing in different assumptions on demand, pricing, and cost trajectory.

The other key takeaway from the notes is balance sheet discipline. Several reports referenced funding expansion largely through internal accruals, which is typically viewed as supportive during large capacity buildouts. Investors are also likely to track how quickly new and acquired assets move toward market margins, since that can influence consolidated EBITDA trend.

Conclusion

UltraTech Cement’s gains came alongside a series of reiterated Buy or Accumulate calls and higher target prices, with brokerages focusing on capacity additions, cost efficiency and medium-term margin improvement. The next set of datapoints investors are likely to track are the delivery on planned capacity additions in Q4FY26 and FY27E, and how pricing and fuel-cost trends shape profitability versus the risk factors highlighted in brokerage notes.